Skip to main content

Life threatening liver disease during treatment with monoclonal antibodies.

Publication ,  Journal Article
Kaiser, T; Moessner, J; Patel, K; McHutchison, JG; Tillmann, HL
Published in: BMJ
February 18, 2009

Duke Scholars

Published In

BMJ

DOI

EISSN

1756-1833

Publication Date

February 18, 2009

Volume

338

Start / End Page

b508

Location

England

Related Subject Headings

  • Recurrence
  • Psoriasis
  • Male
  • Jaundice
  • Immunosuppressive Agents
  • Humans
  • Hepatitis B, Chronic
  • General & Internal Medicine
  • Critical Illness
  • Chemical and Drug Induced Liver Injury, Chronic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kaiser, T., Moessner, J., Patel, K., McHutchison, J. G., & Tillmann, H. L. (2009). Life threatening liver disease during treatment with monoclonal antibodies. BMJ, 338, b508. https://doi.org/10.1136/bmj.b508
Kaiser, Thorsten, Joachim Moessner, Keyur Patel, John G. McHutchison, and Hans L. Tillmann. “Life threatening liver disease during treatment with monoclonal antibodies.BMJ 338 (February 18, 2009): b508. https://doi.org/10.1136/bmj.b508.
Kaiser T, Moessner J, Patel K, McHutchison JG, Tillmann HL. Life threatening liver disease during treatment with monoclonal antibodies. BMJ. 2009 Feb 18;338:b508.
Kaiser, Thorsten, et al. “Life threatening liver disease during treatment with monoclonal antibodies.BMJ, vol. 338, Feb. 2009, p. b508. Pubmed, doi:10.1136/bmj.b508.
Kaiser T, Moessner J, Patel K, McHutchison JG, Tillmann HL. Life threatening liver disease during treatment with monoclonal antibodies. BMJ. 2009 Feb 18;338:b508.

Published In

BMJ

DOI

EISSN

1756-1833

Publication Date

February 18, 2009

Volume

338

Start / End Page

b508

Location

England

Related Subject Headings

  • Recurrence
  • Psoriasis
  • Male
  • Jaundice
  • Immunosuppressive Agents
  • Humans
  • Hepatitis B, Chronic
  • General & Internal Medicine
  • Critical Illness
  • Chemical and Drug Induced Liver Injury, Chronic